NBGNX | VISGX | NBGNX / VISGX | |
Total Expense Ratio | 0.99 | 0.19 | 521% |
Annual Report Gross Expense Ratio | 0.99 | 0.19 | 521% |
Fund Existence | 37 years | 27 years | - |
Gain YTD | -4.098 | 7.310 | -56% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.71B | 39.1B | 22% |
Annual Yield % from dividends | 0.00 | 0.44 | - |
Returns for 1 year | -10.34 | 10.18 | -102% |
Returns for 3 years | 5.11 | 49.62 | 10% |
Returns for 5 years | -3.55 | 31.06 | -11% |
Returns for 10 years | -2.85 | 147.79 | -2% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SAGWX | 6.33 | 0.04 | +0.64% |
Touchstone Small Company A | |||
JFNNX | 75.60 | 0.47 | +0.63% |
Janus Henderson Global Life Sciences N | |||
GMVRX | 16.40 | 0.04 | +0.24% |
Goldman Sachs Small/Mid Cap Equity R | |||
RLBGX | 39.04 | 0.04 | +0.10% |
American Funds American Balanced R6 | |||
KSOAX | 155.80 | -0.51 | -0.33% |
Kinetics Small Cap Opportunities Adv A |